Bispecific Antibody Drug Market - Global Outlook and Forecast 2021-2027

March 2021 | 107 pages | ID: B72AC1D8224BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bispecific Antibody Drug in Global, including the following market information:

Global Bispecific Antibody Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Bispecific Antibody Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific Antibody Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bispecific Antibody Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Bispecific Antibody Drug Market Segment Percentages, By Type, 2020 (%)

• Fragment-Based
• IgG-Based

China Bispecific Antibody Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Bispecific Antibody Drug Market Segment Percentages, By Application, 2020 (%)

• Cancer
• Haemophilia
• Other Diseases

Global Bispecific Antibody Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Bispecific Antibody Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Bispecific Antibody Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Bispecific Antibody Drug Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Amgen
• Sanofi
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Abbvie
• Lindis Biotech
• MacroGenics
• Genmab
• Immunocore Limited
• Xencor
• Merck
• Affimed
• Alphamab
• Akeso
• BeiGene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bispecific Antibody Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bispecific Antibody Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BISPECIFIC ANTIBODY DRUG OVERALL MARKET SIZE

2.1 Global Bispecific Antibody Drug Market Size: 2021 VS 2027
2.2 Global Bispecific Antibody Drug Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bispecific Antibody Drug Players in Global Market
3.2 Top Global Bispecific Antibody Drug Companies Ranked by Revenue
3.3 Global Bispecific Antibody Drug Revenue by Companies
3.4 Top 3 and Top 5 Bispecific Antibody Drug Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bispecific Antibody Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bispecific Antibody Drug Players in Global Market
  3.6.1 List of Global Tier 1 Bispecific Antibody Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bispecific Antibody Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bispecific Antibody Drug Market Size Markets, 2021 & 2027
  4.1.2 Fragment-Based
  4.1.3 IgG-Based
4.2 By Type - Global Bispecific Antibody Drug Revenue & Forecasts
  4.2.1 By Type - Global Bispecific Antibody Drug Revenue, 2016-2021
  4.2.2 By Type - Global Bispecific Antibody Drug Revenue, 2022-2027
  4.2.3 By Type - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bispecific Antibody Drug Market Size, 2021 & 2027
  5.1.2 Cancer
  5.1.3 Haemophilia
  5.1.4 Other Diseases
5.2 By Application - Global Bispecific Antibody Drug Revenue & Forecasts
  5.2.1 By Application - Global Bispecific Antibody Drug Revenue, 2016-2021
  5.2.2 By Application - Global Bispecific Antibody Drug Revenue, 2022-2027
  5.2.3 By Application - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Bispecific Antibody Drug Market Size, 2021 & 2027
6.2 By Region - Global Bispecific Antibody Drug Revenue & Forecasts
  6.2.1 By Region - Global Bispecific Antibody Drug Revenue, 2016-2021
  6.2.2 By Region - Global Bispecific Antibody Drug Revenue, 2022-2027
  6.2.3 By Region - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Bispecific Antibody Drug Revenue, 2016-2027
  6.3.2 US Bispecific Antibody Drug Market Size, 2016-2027
  6.3.3 Canada Bispecific Antibody Drug Market Size, 2016-2027
  6.3.4 Mexico Bispecific Antibody Drug Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Bispecific Antibody Drug Revenue, 2016-2027
  6.4.2 Germany Bispecific Antibody Drug Market Size, 2016-2027
  6.4.3 France Bispecific Antibody Drug Market Size, 2016-2027
  6.4.4 U.K. Bispecific Antibody Drug Market Size, 2016-2027
  6.4.5 Italy Bispecific Antibody Drug Market Size, 2016-2027
  6.4.6 Russia Bispecific Antibody Drug Market Size, 2016-2027
  6.4.7 Nordic Countries Bispecific Antibody Drug Market Size, 2016-2027
  6.4.8 Benelux Bispecific Antibody Drug Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Bispecific Antibody Drug Revenue, 2016-2027
  6.5.2 China Bispecific Antibody Drug Market Size, 2016-2027
  6.5.3 Japan Bispecific Antibody Drug Market Size, 2016-2027
  6.5.4 South Korea Bispecific Antibody Drug Market Size, 2016-2027
  6.5.5 Southeast Asia Bispecific Antibody Drug Market Size, 2016-2027
  6.5.6 India Bispecific Antibody Drug Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Bispecific Antibody Drug Revenue, 2016-2027
  6.6.2 Brazil Bispecific Antibody Drug Market Size, 2016-2027
  6.6.3 Argentina Bispecific Antibody Drug Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bispecific Antibody Drug Revenue, 2016-2027
  6.7.2 Turkey Bispecific Antibody Drug Market Size, 2016-2027
  6.7.3 Israel Bispecific Antibody Drug Market Size, 2016-2027
  6.7.4 Saudi Arabia Bispecific Antibody Drug Market Size, 2016-2027
  6.7.5 UAE Bispecific Antibody Drug Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Bispecific Antibody Drug Major Product Offerings
  7.1.4 Roche Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Bispecific Antibody Drug Major Product Offerings
  7.2.4 Amgen Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.2.5 Amgen Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Bispecific Antibody Drug Major Product Offerings
  7.3.4 Sanofi Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.3.5 Sanofi Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Bispecific Antibody Drug Major Product Offerings
  7.4.4 Pfizer Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.4.5 Pfizer Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Bispecific Antibody Drug Major Product Offerings
  7.5.4 Johnson & Johnson Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.5.5 Johnson & Johnson Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Bispecific Antibody Drug Major Product Offerings
  7.6.4 AstraZeneca Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.6.5 AstraZeneca Key News
7.7 Abbvie
  7.7.1 Abbvie Corporate Summary
  7.7.2 Abbvie Business Overview
  7.7.3 Abbvie Bispecific Antibody Drug Major Product Offerings
  7.4.4 Abbvie Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.7.5 Abbvie Key News
7.8 Lindis Biotech
  7.8.1 Lindis Biotech Corporate Summary
  7.8.2 Lindis Biotech Business Overview
  7.8.3 Lindis Biotech Bispecific Antibody Drug Major Product Offerings
  7.8.4 Lindis Biotech Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.8.5 Lindis Biotech Key News
7.9 MacroGenics
  7.9.1 MacroGenics Corporate Summary
  7.9.2 MacroGenics Business Overview
  7.9.3 MacroGenics Bispecific Antibody Drug Major Product Offerings
  7.9.4 MacroGenics Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.9.5 MacroGenics Key News
7.10 Genmab
  7.10.1 Genmab Corporate Summary
  7.10.2 Genmab Business Overview
  7.10.3 Genmab Bispecific Antibody Drug Major Product Offerings
  7.10.4 Genmab Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.10.5 Genmab Key News
7.11 Immunocore Limited
  7.11.1 Immunocore Limited Corporate Summary
  7.11.2 Immunocore Limited Business Overview
  7.11.3 Immunocore Limited Bispecific Antibody Drug Major Product Offerings
  7.11.4 Immunocore Limited Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.11.5 Immunocore Limited Key News
7.12 Xencor
  7.12.1 Xencor Corporate Summary
  7.12.2 Xencor Business Overview
  7.12.3 Xencor Bispecific Antibody Drug Major Product Offerings
  7.12.4 Xencor Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.12.5 Xencor Key News
7.13 Merck
  7.13.1 Merck Corporate Summary
  7.13.2 Merck Business Overview
  7.13.3 Merck Bispecific Antibody Drug Major Product Offerings
  7.13.4 Merck Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.13.5 Merck Key News
7.14 Affimed
  7.14.1 Affimed Corporate Summary
  7.14.2 Affimed Business Overview
  7.14.3 Affimed Bispecific Antibody Drug Major Product Offerings
  7.14.4 Affimed Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.14.5 Affimed Key News
7.15 Alphamab
  7.15.1 Alphamab Corporate Summary
  7.15.2 Alphamab Business Overview
  7.15.3 Alphamab Bispecific Antibody Drug Major Product Offerings
  7.15.4 Alphamab Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.15.5 Alphamab Key News
7.16 Akeso
  7.16.1 Akeso Corporate Summary
  7.16.2 Akeso Business Overview
  7.16.3 Akeso Bispecific Antibody Drug Major Product Offerings
  7.16.4 Akeso Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.16.5 Akeso Key News
7.17 BeiGene
  7.17.1 BeiGene Corporate Summary
  7.17.2 BeiGene Business Overview
  7.17.3 BeiGene Bispecific Antibody Drug Major Product Offerings
  7.17.4 BeiGene Bispecific Antibody Drug Revenue in Global (2016-2021)
  7.17.5 BeiGene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bispecific Antibody Drug Market Opportunities & Trends in Global Market
Table 2. Bispecific Antibody Drug Market Drivers in Global Market
Table 3. Bispecific Antibody Drug Market Restraints in Global Market
Table 4. Key Players of Bispecific Antibody Drug in Global Market
Table 5. Top Bispecific Antibody Drug Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bispecific Antibody Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bispecific Antibody Drug Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bispecific Antibody Drug Product Type
Table 9. List of Global Tier 1 Bispecific Antibody Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific Antibody Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Bispecific Antibody Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Bispecific Antibody Drug Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Bispecific Antibody Drug Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Bispecific Antibody Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Bispecific Antibody Drug Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Bispecific Antibody Drug Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Bispecific Antibody Drug Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Bispecific Antibody Drug Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Bispecific Antibody Drug Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Bispecific Antibody Drug Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Bispecific Antibody Drug Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Bispecific Antibody Drug Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Bispecific Antibody Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Bispecific Antibody Drug Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Bispecific Antibody Drug Product Offerings
Table 32. Roche Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 33. Amgen Corporate Summary
Table 34. Amgen Bispecific Antibody Drug Product Offerings
Table 35. Amgen Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Bispecific Antibody Drug Product Offerings
Table 38. Sanofi Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Bispecific Antibody Drug Product Offerings
Table 41. Pfizer Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Bispecific Antibody Drug Product Offerings
Table 44. Johnson & Johnson Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Bispecific Antibody Drug Product Offerings
Table 47. AstraZeneca Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 48. Abbvie Corporate Summary
Table 49. Abbvie Bispecific Antibody Drug Product Offerings
Table 50. Abbvie Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 51. Lindis Biotech Corporate Summary
Table 52. Lindis Biotech Bispecific Antibody Drug Product Offerings
Table 53. Lindis Biotech Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 54. MacroGenics Corporate Summary
Table 55. MacroGenics Bispecific Antibody Drug Product Offerings
Table 56. MacroGenics Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 57. Genmab Corporate Summary
Table 58. Genmab Bispecific Antibody Drug Product Offerings
Table 59. Genmab Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 60. Immunocore Limited Corporate Summary
Table 61. Immunocore Limited Bispecific Antibody Drug Product Offerings
Table 62. Immunocore Limited Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 63. Xencor Corporate Summary
Table 64. Xencor Bispecific Antibody Drug Product Offerings
Table 65. Xencor Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 66. Merck Corporate Summary
Table 67. Merck Bispecific Antibody Drug Product Offerings
Table 68. Merck Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 69. Affimed Corporate Summary
Table 70. Affimed Bispecific Antibody Drug Product Offerings
Table 71. Affimed Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 72. Alphamab Corporate Summary
Table 73. Alphamab Bispecific Antibody Drug Product Offerings
Table 74. Alphamab Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 75. Akeso Corporate Summary
Table 76. Akeso Bispecific Antibody Drug Product Offerings
Table 77. Akeso Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)
Table 78. BeiGene Corporate Summary
Table 79. BeiGene Bispecific Antibody Drug Product Offerings
Table 80. BeiGene Bispecific Antibody Drug Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Bispecific Antibody Drug Segment by Type
Figure 2. Bispecific Antibody Drug Segment by Application
Figure 3. Global Bispecific Antibody Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Bispecific Antibody Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Bispecific Antibody Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bispecific Antibody Drug Revenue in 2020
Figure 8. By Type - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 9. By Application - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 10. By Region - Global Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 11. By Country - North America Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 12. US Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 16. Germany Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 17. France Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 24. China Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 28. India Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 30. Brazil Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Bispecific Antibody Drug Revenue Market Share, 2016-2027
Figure 33. Turkey Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Bispecific Antibody Drug Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Amgen Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pfizer Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Johnson & Johnson Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AstraZeneca Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Abbvie Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Lindis Biotech Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. MacroGenics Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Genmab Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Immunocore Limited Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Xencor Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Merck Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Affimed Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Alphamab Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Akeso Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. BeiGene Bispecific Antibody Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)